Filtered By:
Procedure: Heart Valve Surgery
Therapy: Dialysis
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 177 results found since Jan 2013.
Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis
CONCLUSIONS: PVE carried significant perioperative risks, and was an independent risk factor of overall mortality.PMID:34085423 | PMC:PMC8176072 | DOI:10.4070/kcj.2020.0448
Source: Korean Circulation Journal - June 4, 2021 Category: Cardiology Authors: Won Kyung Pyo Ho Jin Kim Joon Bum Kim Sung Ho Jung Suk Jung Choo Cheol Hyun Chung Jae Won Lee Source Type: research
STratification risk analysis in OPerative management (STOP score) for drug ‐induced endocarditis
CONCLUSIONDrug ‐related IE is associated with significant morbidity and mortality. An easily‐applied risk stratification score may aid in clinical decision‐making.
Source: Journal of Cardiac Surgery - April 25, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Andreas Habertheuer,
Arnar Geirsson,
Thomas Gleason,
Joseph Woo,
Bryan Whitson,
George J Arnaoutakis,
Pavan Atluri,
Arminder Jassar,
Tsuyoshi Kaneko,
Arman Kilic,
Paul C Tang,
Asher J. Schranz,
Syed Usman Bin Mahmood,
Makoto Mori,
Ibrahim Su Tags: ORIGINAL ARTICLE Source Type: research
Aortic root remodeling with external annuloplasty for acute type A aortic dissection: Midterm results
ConclusionIn a center with expertise in valve ‐sparing procedures, ARREAA is a reasonable option in the surgical management of AAAD in selected patients. This technique stabilizes the aortic annulus and preserves root anatomy for durable outcomes.
Source: Journal of Cardiac Surgery - April 14, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Marie ‐Catherine Morgant,
Ghislain Malapert,
Chloé Bernard,
Aline Laubriet,
Charline Pujos,
Thomas Varin,
Emmanuel Lansac,
Olivier Bouchot Tags: Special Section: Trend & Controversies in Type A Aortic Surgery in 21st Century Source Type: research
New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Aortic root remodeling with external annuloplasty for acute type A aortic dissection: Midterm results
ConclusionIn a center with expertise in valve ‐sparing procedures, ARREAA is a reasonable option in the surgical management of AAAD in selected patients. This technique stabilizes the aortic annulus and preserves root anatomy for durable outcomes.
Source: Journal of Cardiac Surgery - October 8, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Marie ‐Catherine Morgant,
Ghislain Malapert,
Chloé Bernard,
Aline Laubriet,
Charline Pujos,
Thomas Varin,
Emmanuel Lansac,
Olivier Bouchot Tags: ORIGINAL ARTICLE Source Type: research
Minimally ‐invasive parasternal aortic valve replacement–A slow learning curve towards improved outcomes
ConclusionsParasternal minimally ‐invasive aortic valve replacement is a feasible technique associated with a slow learning curve but the potential to achieve improved outcomes. Considering the transcatheter alternatives, the relative risk reduction may be worth investigating in future trials.
Source: Journal of Cardiac Surgery - January 14, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Sophio Tkebuchava,
Gloria F ärber,
Christoph Sponholz,
Frank Fuchs,
Petra Heinisch,
Michael Bauer,
Torsten Doenst Tags: ORIGINAL ARTICLE Source Type: research
Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy
ConclusionsSeptal myectomy, performed in a tertiary referral center, had a 30-day mortality rate of 0% and low morbidity rate. There was no difference between observed myectomy mortality and STS Calculator predicted risk for AVR and MV repair. It is possible that a larger sample could reveal lower mortality than STS prediction.
Source: American Heart Journal - December 19, 2019 Category: Cardiology Source Type: research
Predictors of Cumulative Health Care Costs Associated with Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis
ConclusionsThis analysis shows that there are 3 distinct phases of cost accumulation from referral to post-TAVR with some potentially modifiable cost drivers in each phase.
Source: Canadian Journal of Cardiology - December 18, 2019 Category: Cardiology Source Type: research
Predictors and outcomes of stroke after transcatheter aortic valve replacement
ConclusionsAlternative access approach and a history of transient ischemic attack emerged as independent predictors of postoperative stroke. Patients with stroke suffered more complications and had worse survival, underscoring the importance of characterizing the stroke risk in these patients.
Source: Journal of Cardiac Surgery - December 2, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Sarah A. Hatfield,
Marcos A. Nores,
Taylor M. James,
Mark Rothenberg,
Arvind Kapila,
Roberto J. Cubeddu,
Sotiris C. Stamou Tags: ORIGINAL ARTICLE Source Type: research
A Multi Center Experience: Is Valve Replacement Safe for Patients with Hugely Dilated Left Ventricle?
CONCLUSION: Valve replacement in patients with hugely dilated left ventricle are safe operations with satisfactory outcomes even if combined with other procedures, especially with proper preoperative preparation, intraoperative preservation of posterior mitral leaflet, and meticulous postoperative follow up in the surgical ICU.
PMID: 31895029 [PubMed - in process]
Source: The Heart Surgery Forum - November 24, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Ahmed A, Toema A, Yehia A, Hashim Y, Elkahely M, Onsy A Tags: Heart Surg Forum Source Type: research
TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry
ConclusionsPatients with prior SMVR undergoing TAVR had similar 30-day outcomes, slightly higher 1-year mortality, and no increase in early PVL compared to those without previous SMVR. Prior SMVR should not preclude TAVR in appropriately selected patients.
Source: The Annals of Thoracic Surgery - October 24, 2019 Category: Cardiovascular & Thoracic Surgery Source Type: research
TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry.
CONCLUSIONS: Patients with prior SMVR undergoing TAVR had similar 30-day outcomes, slightly higher 1-year mortality, and no increase in early PVL compared to those without previous SMVR. Prior SMVR should not preclude TAVR in appropriately selected patients.
PMID: 31655043 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - October 22, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Thourani VH, Kelly JJ, Cervantes D, Vemulapalli S, Manandhar P, Forcillo J, Holmes D, Cohen DJ, Kirtane A, Kodali S, Leon M, Babaliaros V, Waksman R, Satler L, Shults C, Ben-Dor I, Rogers T, Kapadia S, Reardon M, Chris Malaisrie S, Gleason T, Holper EM, B Tags: Ann Thorac Surg Source Type: research
A Blood Filter Fights Deadly Inflammatory Response
A new blood filtration technology may prove to be life-saving for patients whose normally healthy inflammatory response to injury or illness has gone into overdrive, resulting in fatally high levels of cytokines in their blood. In an interview with MD+DI, Dr. Phillip Chan, MD, PhD, CEO of CytoSorbents Corp., explained that inflammation, and the production of substances called cytokines that drive inflammation, are the body’s natural response to heal injury or infection. But sometimes, the inflammatory response is so severe in such conditions as sepsis and infection, burn injuries, trauma, pancreatitis, li...
Source: MDDI - October 9, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Cardiovascular Source Type: news
